OTHER GROUP COMPANIES
- Login to Trade
- Login to DP
- Karvy Customer
-
OTHER GROUP COMPANIES
-
- Home
Solara Active Pharma Sciences rose 4.16% to Rs 1095.85 after Sequent Scientific acquired 1.54% stake in the company during October-December 2021 quarter.
In shareholding pattern of the company for September 2021 quarter, Sequent Scientifics name was not present in shareholders list.
As on December 2021, promoter & promoter group held 39.51% in Solara Active Pharma Sciences.
Solara Active Pharma Sciences is a pure-play global Active Pharmaceutical Ingredient (API) company. It traces its origins to the API expertise of Strides Shasun and the technical know-how of human API business from Sequent Scientific.
In 2018, Strides Shasun demerged its commodity API business and Sequent Scientific demerged its Human API business to form Solara Active Pharma Sciences.
Solara has 140+ scientists working at its two R&D centers and 5 API manufacturing facilities armed with global approvals and 2 dedicated R&D facilities.
Shares of Solara Active Pharma Sciences have risen 5.90% in two consecutive trading session.
In the past one year, the stock has fallen 9.20% while the benchmark Sensex has added 23.67% during the same period.
On a consolidated basis, net profit of Solara Active Pharma Sciences declined 47.57% to Rs 29.71 crore on 1.02% rise in net sales to Rs 401.61 crore in Q2 September 2021 over Q2 September 2020.
Powered by Capital Market - Live News
May 24, 2022
May 24, 2022
May 24, 2022
May 24, 2022
May 24, 2022
May 24, 2022
May 24, 2022
May 24, 2022
May 24, 2022
May 24, 2022
May 24, 2022
May 24, 2022
May 24, 2022
May 24, 2022
May 24, 2022
The laws of the financial world are different from the physical world. You can have prolonged periods of time, when sanity takes a back seat and excesses happen.
R. Venkataraman Aug 20, 2021
Retail trading or day trading has exploded because of falling brokerage rates, democratization of information, higher transparency and mobile platforms.
R. Venkataraman Jun 15, 2021
My simple message for dear readers is, if you don’t have any desperate need for funds, then don’t do anything.
R. Venkataraman May 12, 2021
The blow up of a US hedge fund has resulted in WhatsApp university offering many courses on what went wrong with Bill Hwang and Archegos.
R. Venkataraman Apr 09, 2021
The expensive valuations have been sustained by strong rebound in corporate earnings which led to ~8% upgrade in FY22 Nifty EPS since October 2020.
R. Venkataraman Mar 26, 2021
We believe the interest rates are likely to have bottomed due to inflationary pressure, large government borrowings and normalizing credit growth. Hence rate sensitive sectors should be avoided in our view.
R. Venkataraman Feb 17, 2021
As markets make new highs, one gets more emails and messages, which highlight the accomplishments of traders who have found a formula for making money.
R. Venkataraman Jan 27, 2021
Data does not seem to convincingly prove that short periods of high returns are always followed by meagre returns. Only in 4 instances, we had negative returns in the subsequent year.
R. Venkataraman Jan 01, 2021
Since September end, Bankex is up 16% with large banks like ICICI Bank, Bandhan up 20-27%, Housing Finance Companies like Repco, LICHF, PNB Housing are up 50%-100% from their six-month lows.
R. Venkataraman Oct 13, 2020
Morgan Housel’s 'The Psychology of Money' explains in detail the role of human biases in investment decisions.
R. Venkataraman Sep 26, 2020
Per Order for ETF & Mutual Funds Brokerage
Per Order for Delivery, Intraday, F&O, Currency & Commodity
